Professor in Medicine
University of Galway, Ireland, Ireland
Prof. John J. Carey is a physician in rheumatology and medicine at Galway University Hospitals, and Professor in Medicine at University of Galway, Ireland. Prof. Carey completed his undergraduate training in University College Dublin, Ireland, and his post-graduate training in medicine, rheumatology and clinical research in Dublin (Ireland), and Boston (USA) and Cleveland (USA). He is past-president of The International Society for Clinical Densitometry (ISCD), faculty for OE, VFR, Body Comp and Pediatric courses, current president of The Irish DXA Society, a member of International Osteoporosis Foundation’s Committee for Scientific Affairs and The European Calcified Tissue Society’s Clinical Action Group. His research focusses on big data, imaging, reality and evidence-based medicine.
Tuesday, March 28, 2023
8:00 AM – 5:00 PM
Disclosure(s): Abbvie, Ireland: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Amgen Ireland and Europe: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Contracted Research (PI’s must provide disclosure in this category) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Eli Lilly, Ireland: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Nordic Pharma: Other (Terminated, January 30, 2023); Pfizer Ireland, UK, Europe, Brazil and Canada: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023)
Friday, March 31, 2023
3:45 PM – 4:45 PM
Disclosure(s): Abbvie, Ireland: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Amgen Ireland and Europe: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Contracted Research (PI’s must provide disclosure in this category) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Eli Lilly, Ireland: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023); Nordic Pharma: Other (Terminated, January 30, 2023); Pfizer Ireland, UK, Europe, Brazil and Canada: Consulting Fee (e.g., Advisory Boards) (Terminated, January 30, 2023), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Terminated, January 30, 2023)